Alsaadi T

ORCID: 0000-0002-7513-5706 · 2 papers in corpus

observational 2026

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE

Neurology and therapy ·doi:10.1007/s40120-026-00961-9

INTRODUCTION: Atogepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for migraine prevention; however, real-world data from the Middle East and North Africa (MENA) region remain limited. This study evaluate…

observational 2026

Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study.

European journal of neurology ·doi:10.1111/ene.70597

BackgroundRecent post-marketing studies have indicated a possible association between anti-CGRP receptor monoclonal antibodies (anti-CGRP-mAbs) used for migraine prophylaxis and an increased risk of hypertension (HT).MethodsWe performed a r…